Calls for More Diverse Infrastructure Upgrades to US Emergency Trials Framework | Trial AMPlify

Jonathan Eilberg • March 22, 2023

The lobbying group PhRMA Tuesday called for more clinical trial diversity in underserved areas, and suggested educating more people on the role of clinical trials and building trust in those communities with historic records of previous mistreatment in studies. But how?

"We welcome the call for emergency clinical trial infrastructure improvements," commented Jon Eilberg, founder and CEO and Trial AMPlify, a Boston-based patient recruitment marketing agency working exclusively with life science, biopharma companies to surge clinical trial patient enrollment.

 

A recent analysis showed that although men and women have an equal risk of stroke, only 37% of participants in clinical trials of stroke treatments are female. Another analysis found that although Black adults are two times more likely to develop hypertension by middle age than white adults, only about 5 percent of hypertension clinical trials in recent years have focused specifically on black participants.

 

Clinical trial sponsors need to be more creative when it comes to communicating with potential subjects. Simply listing a study on clinicaltrials.gov and expecting a diverse number of patients to flock for treatment is not a realistic plan. As part of the Seven Miracles of Patient Recruitment, sponsors need to 1) create awareness across digital channels using dedicated clinical trial landing pages, 2) clearly convey objectives, eligibility, and logistics, 3) and drive home the sometimes overlooked benefits of being part of a trial.

 

By carefully crafting the messaging to meet regulatory restrictions, sponsors can make it clear to a patient and their families that they will receive more "attention" and monitoring. Prominently stating monetary compensation up front in some cases also incentivizes patients. Using different racial and ethnic images on a dedicated clinical trial website along with a design theme that speaks to the ideal candidate can also make the thought of enrolling more inviting.

 

Finally, supplementing a clinical trial landing page with an online natural history study that uses success stories coming from women, people of color, and their families is a powerful way to help folks to connect, see the upside of a trial, and inspire them to engage.”

Muli-Site Clinical Trials
By Jonathan Eilberg December 4, 2025
Trial AMPlify reveals the common recruitment errors in multi-site clinical trials and strategies to prevent delays, inefficiencies, and low enrollment rates.
Clnical Trial Enrollment
By Jonathan Eilberg November 25, 2025
In today’s fast-evolving clinical research landscape, clinical trial enrollment has become one of the biggest bottlenecks for sponsors and CROs. Traditional recruitment methods often fall short, leading to delayed timelines and skyrocketing costs. Fortunately, digital strategies are transforming clinical trial patient enrollment by connecting studies with qualified patients faster and more efficiently than ever before. Industry data shows that trials leveraging digital-first recruitment strategies can see over 150% more prequalified inquiries and shorten enrollment timelines by more than four months compared to conventional approaches. These gains are critical when 80% of clinical trials fail to meet enrollment deadlines.  By embracing targeted digital advertising for clinical trials, sponsors can reduce risk, accelerate study start-up, and bring life-changing therapies to patients sooner.
Patient Recruitment Companies
By Jonathan Eilberg November 16, 2025
Trial AMPlify reveals why biopharma firms rely on patient recruitment companies to streamline trials, boost enrollment, and ensure faster study completion.
How Clinical Trial Recruitment Companies Prevent Delays
By Jonathan Eilberg November 13, 2025
Trial AMPlify explains how clinical trial recruitment companies solve patient enrollment challenges and reduce delays in clinical research. Learn more.
Patient Recruitment Marketing
By Jonathan Eilberg November 11, 2025
Trial AMPlify explores the common pitfalls in patient recruitment marketing. Learn 7 key mistakes sponsors make in clinical trials and how to fix them.
Decentralized Clinical Trials (DCTs)
By Jonathan Eilberg November 6, 2025
Learn how Clinical Trial Recruitment Companies enhance decentralized trials with patient-centric recruitment and advanced digital solutions.
Clinical Trial Recruitment Company
By Jon Eilberg July 22, 2025
Discover the top 9 factors to select the best patient recruitment agency for your clinical trial and see why Trial AMPlify leads in the clinical trial marketing space with unmatched performance and a 100% design guarantee.
Advantages of a dedicated clinical trial website versus using clinicaltrials.gov
By Jonathan Eilberg March 18, 2025
Trial AMPlify explores why you should be using a dedicated clinical trial website versus your clinicaltrials.gov as the face of your study for patient recruitment.
Patient Recruitment Company
By Trial AMPlify - A Leading Patient Recruitment Company January 23, 2025
Trial AMPlify helps define what a patient recruitment agency does and the ways it can help sponsors and CROs enroll eligible and diverse study subjects.
Plaque Psoriasis
By Jonathan Eilberg January 15, 2025
Trial AMPlify, a leader in clinical trial landing page design, launches a study site for Alumis to investigate a new psoriasis medication.